Jazz Pharmaceuticals Balance Sheet
NASDAQ: JAZZHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Jazz Pharmaceuticals financial position
At the end of fiscal 2025, Jazz Pharmaceuticals reported total assets of $11.66 billion, down 2.9% from a year earlier against total liabilities of $7.34 billion. Shareholders' equity stood at $4.32 billion, or 37.0% of assets. The company held $1.39 billion in cash and equivalents against $5.36 billion of debt, a net debt position of $3.97 billion.
The current ratio (current assets divided by current liabilities) was 1.86, meaning short-term assets cover obligations due within a year. Debt-to-equity was 1.24.
Summary generated from market data by MetaCap's automated system. Methodology
Jazz Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.39B | 2.41B | 1.51B | 881.48M | 591.45M | 1.06B | 637.34M | 309.62M | 386.04M | 365.96M |
| Receivables | 830.70M | 716.76M | 705.79M | 651.49M | 563.36M | 396.49M | 355.99M | 263.84M | 224.13M | 234.24M |
| Inventory | 417.00M | 480.44M | 597.04M | 714.06M | 1.07B | 95.40M | 78.61M | 52.96M | 43.24M | 34.05M |
| Total Current Assets | 4.17B | 4.63B | 3.44B | 2.61B | 2.61B | 2.84B | 1.63B | 1.23B | 968.28M | 748.07M |
| Property, Plant & Equipment | 199.90M | 173.41M | 169.65M | 228.05M | 256.84M | 127.94M | 131.51M | 200.36M | 170.08M | 107.49M |
| Goodwill | 1.83B | 1.72B | 1.75B | 1.69B | 1.83B | 958.30M | 920.02M | 927.63M | 947.54M | 893.81M |
| Intangible Assets | 4.43B | 4.76B | 5.42B | 5.79B | 7.15B | 2.20B | 2.44B | 2.73B | 2.98B | 3.01B |
| Total Assets | 11.66B | 12.01B | 11.39B | 10.84B | 12.30B | 6.54B | 5.54B | 5.20B | 5.12B | 4.80B |
| Accounts Payable | 122.10M | 77.87M | 102.75M | 90.76M | 100.30M | 26.95M | 45.73M | 40.60M | 24.37M | 22.41M |
| Short-Term Debt | 1.03B | 31.00M | 604.95M | 31.00M | 31.00M | 246.32M | 33.39M | 33.39M | 40.60M | 36.09M |
| Total Current Liabilities | 2.24B | 1.04B | 1.54B | 933.19M | 809.30M | 653.75M | 364.49M | 345.49M | 293.95M | 257.41M |
| Long-Term Debt | 4.33B | 6.08B | 5.11B | 5.69B | 6.02B | 1.85B | 1.57B | 1.56B | 1.54B | 1.99B |
| Total Liabilities | 7.34B | 7.92B | 7.66B | 7.75B | 8.33B | 2.88B | 2.43B | 2.45B | 2.41B | 2.92B |
| Shareholders' Equity | 4.32B | 4.09B | 3.74B | 3.09B | 3.97B | 3.66B | 3.11B | 2.76B | 2.71B | 1.88B |
| Retained Earnings | 646.10M | 1.13B | 878.66M | 733.59M | 830.23M | 1.16B | 1.07B | 841.05M | 917.96M | 528.91M |
| Total Debt | 5.36B | 6.11B | 5.71B | 5.72B | 6.05B | 2.09B | 1.61B | 1.60B | 1.58B | 2.03B |
| Net Cash (Debt) | -3.97B | -3.70B | -4.21B | -4.84B | -5.46B | -1.04B | -969.91M | -1.29B | -1.20B | -1.66B |
| Shares Outstanding | 61.44M | 60.63M | 62.26M | 63.21M | 61.63M | 56.17M | 56.14M | 57.70M | 58.90M | 59.82M |
This table shows 10 annual periods of Jazz Pharmaceuticals's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow JAZZ's reporting calendar. What is a balance sheet?